We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVLY icon
4101
Oak Valley Bancorp
OVLY
$281M
$10.6K ﹤0.01%
419
-1,637
-80% -$39.8K
VRME icon
4102
VerifyMe
VRME
$9.37M
$10.5K ﹤0.01%
7,644
+1,290
+20% +$2.06K
CABA icon
4103
Cabaletta Bio
CABA
$461M
$10.5K ﹤0.01%
817
-4,205
-84% -$45.6K
EXFY icon
4104
Expensify
EXFY
$207M
$10.5K ﹤0.01%
1,321
-1,469
-53% -$10.8K
SBT
4105
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$10.5K ﹤0.01%
1,926
-69
-3% -$362
IEUR icon
4106
iShares Core MSCI Europe ETF
IEUR
$9.13B
$10.5K ﹤0.01%
200
+184
+1,150% +$9.78K
FRST icon
4107
Primis Financial Corp
FRST
$410M
$10.5K ﹤0.01%
1,250
-1,041
-45% -$8.71K
BPTH
4108
DELISTED
Bio-Path Holdings Inc
BPTH
$10.5K ﹤0.01%
295
-29
-9% -$895
SHPW
4109
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$10.5K ﹤0.01%
2,795
-580
-17% -$1.8K
RXT icon
4110
Rackspace Technology
RXT
$1.14B
$10.5K ﹤0.01%
3,863
-35,334
-90% -$58.3K
METCB icon
4111
Ramaco Resources Class B
METCB
$394M
$10.5K ﹤0.01%
+1,068
New +$10.3K
PSET icon
4112
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$29.2M
$10.5K ﹤0.01%
186
-97
-34% -$5.14K
PWP icon
4113
Perella Weinberg Partners
PWP
$1.32B
$10.5K ﹤0.01%
1,259
-171
-12% -$1.41K
NGM
4114
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$10.5K ﹤0.01%
4,048
-723
-15% -$2.58K
TCFC
4115
DELISTED
The Community Financial Corporation Common Stock
TCFC
$10.5K ﹤0.01%
387
-66
-15% -$1.88K
APRE icon
4116
Aprea Therapeutics
APRE
$8.36M
$10.5K ﹤0.01%
3,325
+1,848
+125% +$6.89K
GCMG icon
4117
GCM Grosvenor
GCMG
$845M
$10.5K ﹤0.01%
1,389
-512
-27% -$3.81K
MYFW icon
4118
First Western Financial
MYFW
$308M
$10.5K ﹤0.01%
563
-231
-29% -$4.05K
MTEM
4119
DELISTED
Molecular Templates, Inc.
MTEM
$10.5K ﹤0.01%
1,454
-930
-39% -$6.36K
PAVM icon
4120
PAVmed
PAVM
$32.9M
$10.4K ﹤0.01%
57
-27
-32% -$5.4K
INAB icon
4121
IN8bio
INAB
$9.85M
$10.4K ﹤0.01%
226
+63
+39% +$3.94K
ZURA icon
4122
Zura Bio
ZURA
$545M
$10.4K ﹤0.01%
1,272
+1,172
+1,172% +$9.41K
FAS icon
4123
Direxion Daily Financial Bull 3x ETF
FAS
$2.45B
$10.4K ﹤0.01%
164
-165
-50% -$9.73K
IAUX
4124
i-80 Gold Corp
IAUX
$1.48B
$10.4K ﹤0.01%
4,628
+4,581
+9,747% +$10.8K
LPTH icon
4125
Lightpath Technologies
LPTH
$868M
$10.4K ﹤0.01%
7,712
-23,655
-75% -$32.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.